✦ LIBER ✦

Effects of interferon-α2b treatment onex vivodifferentiation of mast cells from circulating progenitor cells in a patient with systemic mastocytosis

✍ Scribed by G.-H. Schernthaner; E. Spanblöchl; W. R. Sperr; C. Sillaber; H. Semper; W. Jurecka; W. Hagen; K. Wolff; A. Chott; K. Lechner; P. Valent

Book ID: 105990022
Publisher: Springer
Year: 2000
Tongue: English
Weight: 91 KB
Volume: 79
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s002770000206

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cytotoxic and noncytotoxic mechanisms in

Cytotoxic and noncytotoxic mechanisms involved in the in vitro anti-leukaemia effects of T cell clones established from a chronic myelogenous leukaemia patient during treatment in vivo with interferon α

✍ Graham Pawelec; Markus Reutter; Martin Owsianowsky; Arnika Rehbein; Friedrich W. 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 879 KB

Subcutaneous interleukin-2 and interfero

Subcutaneous interleukin-2 and interferon α in the treatment of patients with metastatic renal cell carcinoma—Less efficacy compared with intravenous interleukin-2 and interferon α : Results of a multicenter Phase II trial from the Groupe Français d'Immunothérapie

✍ Alain Ravaud; Rémy Delva; Fréderic Gomez; Christine Chevreau; Jean-Yves Douillar 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 1 views

## Background: The main objective of this trial was to evaluate the combination of subcutaneous (sc) interleukin-2 (il-2) with interferon alpha-2a (ifn-alpha) in the treatment of patients with metastatic renal cell carcinoma (mrcc) compared with a previous trial that used continuous-infusion il-2 a